United States News All stories

Polyrizon (NASDAQ:PLRZ) said it has completed the biocompatibility evaluation program for its NASARIX™ Allergy Blocker nasal spray.

CME Group (NASDAQ:CME) reported record average daily volume of 30.6 million contracts for June 2026, marking a 19% increase compared with the same period last year.

Obsidian Energy (NYSE:OBE) said it has closed its Belly River light oil acquisition in Willesden Green for approximately $98 million.

Dole (NYSE:DOLE) said its subsidiary Dole Nordic AB has completed the acquisition of Greenfood AB’s Fresh Produce division, known as GFP.

VERAXA Biotech (NASDAQ:VRXA) said it has begun cell line development for its lead BiTAC T-cell engager (BiTAC-TCE) candidate.

Alliance Resource Partners (NASDAQ:ARLP) completed its $206.2 million acquisition of oil and gas mineral interests to expand its portfolio.

Arcturus Therapeutics Holdings (NASDAQ:ARCT) announced a strategic collaboration with Thermo Fisher Scientific (NYSE:TMO) to support Phase 3 development and potential commercialization of ARCT-032, its investigational mRNA therapy for cystic fibrosis.

UMH Properties (NYSE:UMH) reported preliminary second-quarter 2026 operating metrics showing total rental and related income increased 10.3% year over year.

Lindsay (NYSE:LNN) reported third-quarter fiscal 2026 revenue of $160.8 million, a 5% decline from $169.5 million in the same period last year.

GFL Environmental (NYSE:GFL) declared a cash dividend of $0.0169 per share for the second quarter of 2026.

United Therapeutics (NASDAQ:UTHR) acquired Thymmune Therapeutics, a preclinical biotechnology company focused on regenerative thymic cell therapies for immune-related diseases.

Ryanair (NASDAQ:RYAAY) reported a 7% increase in June traffic to a new record of 21.2 million guests.

Woodside Energy Group (NYSE:WDS) announced that non-executive director Tony O’Neill will resign from the board effective 1 July 2026.

VEON (NASDAQ:VEON) and Mastercard (NYSE:MA) announced a partnership aimed at expanding access to digital financial services in Ukraine, Kazakhstan, Pakistan, and Uzbekistan.

The Ensign Group (NASDAQ:ENSG) acquired the operations of two skilled nursing facilities in Texas, expanding its healthcare portfolio in the U.S. senior care market.

iQIYI (NASDAQ:IQ) announced a leadership change, appointing Ying Tian as Chief Financial Officer effective July 2, 2026.

Alphabet (NASDAQ:GOOGL) lost its final appeal after the Court of Justice of the European Union upheld a €4.1 billion fine tied to Google’s Android operating system practices.

HUTCHMED (NASDAQ:HCM) received conditional approval from China’s National Medical Products Administration for ORPATHYS® (savolitinib) to treat certain advanced gastric and gastroesophageal junction cancers.

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) announced that the U.S. Food and Drug Administration has approved expanded use of CASGEVY (exagamglogene autotemcel) for the treatment of people ages 2 years and older with either sickle cell disease with recurrent vaso-occlusive crises or transfusion-dependent beta thalassemia.

Telix (NASDAQ:TLX) said the U.S. Food and Drug Administration agreed that safety data from Part 1 of its ProstACT Global Phase 3 trial support progression into Part 2 in the United States.

Abbisko Therapeutics and AstraZeneca (NYSE:AZN) entered a strategic collaboration to develop a combination therapy for patients with EGFR-mutated, PD-L1 positive non-small cell lung cancer (NSCLC).

General Motors (NYSE:GM) reported a 4.2% year-on-year decline in U.S. auto sales for the second quarter, with total deliveries of 714,896 vehicles compared with 746,588 units in the prior-year period.

UniFirst (NYSE:UNF) reported fiscal third-quarter 2026 revenue of $634.4 million, reflecting 3.9% growth compared with the same period last year.

The Patent and Market Court in Stockholm delivered a judgment on Wednesday ordering Alphabet (NASDAQ:GOOGL) to pay 14.3 billion Swedish kronor (€1.3 billion) in antitrust damages.